ARS Pharmaceuticals Investor Relations Material

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for patients and caregivers affected by severe allergic reactions, including anaphylaxis. The company's flagship product in development is Neffy, a needle-free, low-dose intranasal epinephrine nasal spray designed to offer a safe, effective, and user-friendly alternative to traditional injectable epinephrine devices. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.